Accessibility helpSkip to navigationSkip to contentSkip to footer
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign In
  • Home
  • World
    Sections
    • World Home
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    Most Read
    • Hizbollah warns Israel of war ‘without limits’ and threatens Cyprus
    • Armed gangs stage bank heists in Gaza
    • Vladimir Putin seals strategic partnership with North Korea’s Kim Jong Un
    • Giorgia Meloni’s hard-right European group claims a top EU job
    • Israeli military approves plan for ‘offensive’ in Lebanon
  • US
    Sections
    • US Home
    • US Economy
    • Investing in America
    • US Companies
    • US Politics & Policy
    • US Presidential Election 2024
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Permira’s last-minute decision to kill the Golden Goose IPO
      • The Singaporean firm betting on Nigeria amid multinationals’ ‘exodus’
      • Starling steps up legal action against debtors amid defaults and FCA probe
      • Switzerland could lose wealth crown to Hong Kong, UBS chief warns
      • Soaring popularity of Guinness helps pub group Young’s to record profit
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Wealth Management
      • Moral Money
      • ETF Hub
      • Fund Management
      • Trading
      Most Read
      • Nvidia vaults past Apple and Microsoft to become world’s most valuable company
      • News updates from June 19: Hizbollah warns of fight ‘without limits’; UK inflation returns to 2% target
      • Armed gangs stage bank heists in Gaza
      • Starling steps up legal action against debtors amid defaults and FCA probe
      • Most stocks hyped as winners from AI boom have fallen this year
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
      Most Read
      • The mother of all US presidential debates
      • Invested in the WFH argument? Home in on the evidence
      • No, Keir, the real opposition is behind you
      • How not to do industrial policy
      • Don’t blame neoliberalism for the rise of the hard right
    • Lex
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Europe's Start-Up Hubs
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      • Working It
      Most Read
      • Making sense of Gen Z: employers seek answers on managing younger workers
      • Why tackling accent bias matters at work
      • Janus Henderson’s Ali Dibadj: ‘You’ve just got to roll with the punches’
      • Business books: what to read this month
      • Employers should do more than just talk about mental health
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • The FT’s guide to the best books to read this summer
      • Why can’t my parents see the upsides of downsizing?
      • Why watchmakers are obsessed with the lunar cycle
      • Best summer books of 2024: Economics
      • Best summer books of 2024: Environment
    • HTSI
    1. Companies
    2. Health
    • Healthcare
    • Pharmaceuticals
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Lex
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Health

    • Wednesday, 19 June, 2024
      UK government spending
      Extra £38bn a year needed by 2029-30 to ‘revive’ NHS, says think-tank

      Parties ‘need to be honest’ about scale of investment needed to tackle health service crisis in England, warn analysts

      NHS ambulances outside a hospital in London
    • Tuesday, 18 June, 2024
      The Big Read
      The race against time to defeat mosquito-borne diseases

      Researchers are trying to tackle the threat before nature’s ‘flying needles’ become more prevalent and resistant to prevention

    • Saturday, 15 June, 2024
      FT Globetrotter
      A summer in Rome special

      The best gelato, outdoor cinemas, scenic walks at night — and much more

    • Friday, 14 June, 2024
      Food & Beverage
      UK manufacturers recall food products over E.coli risk

      Health authorities link outbreak to salad leaves as companies take ‘precautionary measure’ and pull items

    • Thursday, 13 June, 2024
      Work WatchBethan Staton
      Employers should do more than just talk about mental health

      Workers still fear discrimination despite years of raising awareness — do companies need to go further?

    • Thursday, 13 June, 2024
      Reproductive rights
      US Supreme Court rejects challenge to abortion pill

      Unanimous decision finds plaintiffs lacked standing to sue over regulatory approval of mifepristone

      Abortion-rights supporters rallying outside the US Supreme Court earlier this year
    • Thursday, 13 June, 2024
      NHS England
      NHS waiting lists in England rise to 7.57mn

      First rise in 7 months blow to Rishi Sunak’s claim number is falling

      An anesthetist checks information displayed on electronic screens during an operation inside theater at Queen Elizabeth Hospital Birmingham
    • Wednesday, 12 June, 2024
      Antibiotic resistance
      Rapid tests take aim at antibiotic-resistant ‘superbugs’

      Innovation prize targeting urinary tract infections boosts effort to tackle pathogens that develop immunity to drugs

      An illustration of the bacteria that cause cystitis, or bladder inflammation
    • Wednesday, 12 June, 2024
      Powerful lobbies hobble moves to cut European disease burden

      Alcohol, food, tobacco and fossil fuel sectors oppose efforts to target conditions linked to 2.7mn deaths a year, warns WHO

      Patrons drink at a bar
    • Wednesday, 12 June, 2024
      Anjana Ahuja
      Women have a lot on their Petri dish

      A new WHO survey suggests that they are more exposed than men to superbugs

      Andy Carter illustration of a person standing on a stage the shape of coronavirus in the spotlight
    • Tuesday, 11 June, 2024
      Disease control and prevention
      EU secures 40mn doses of bird flu vaccine as cases rise

      Health authorities move to protect farmworkers and other high-risk groups after recent outbreaks

      Montage of test tubes labelled ‘Bird Flu’ in front of an EU flag
    • Tuesday, 11 June, 2024
      US economy
      America: a healthy or healthcare economy?

      The sickness at the heart of US GDP

    • Tuesday, 11 June, 2024
      Special ReportWomen in Business
      My son, my working mother and childcare

      More women are juggling paid work with looking after grandchildren

      Mature woman embracing a a little girl
    • Monday, 10 June, 2024
      Eli Lilly & Co
      Eli Lilly’s Alzheimer’s drug wins backing of US advisory panel

      Independent experts conclude unanimously that the experimental treatment is effective

      A doctor looks at a PET brain scan
    • Monday, 10 June, 2024
      Moderna
      Moderna hails successful trial of combined Covid and flu shot

      Vaccine maker to seek approval for jab as it tries to diversify product pipeline

      A vial of a Moderna Covid-19 vaccine
    • Sunday, 9 June, 2024
      Jemima Kelly
      Why our brains crave beauty, art and nature

      Neuroaesthetics suggest that engagement with such phenomena is essential, rather than a ‘nice to have’

      Ben Hickey illustration of a painting palette with different colours on it.
    • Saturday, 8 June, 2024
      Pharmaceuticals sector
      Charities create fund to invest in spinal cord injury companies

      Launch highlights growth of venture philanthropy to boost search for treatments and cures

      x-ray shows spinal cord
    • Friday, 7 June, 2024
      The FT ViewThe editorial board
      A new era of personalised cancer treatments

      As incidence rises, breakthroughs in oncology show the value of research funding

      A doctor monitors a CAT scan procedure
    • Friday, 7 June, 2024
      Work WatchEmily Herbert
      Employers seek to ease pressure of fertility treatment for staff

      Stress and need for time off leaves many women with no choice but to quit their job

    • Friday, 7 June, 2024
      Exchange traded funds
      Weight-loss ETFs demand some heavy thinking

      Both OZEM and THNR offer very concentrated bets on a fast-moving market

      A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk
    • Thursday, 6 June, 2024
      Food security
      Conflict and climate shocks fuel food poverty crises

      More than 25% of children under 5 years are suffering severe hunger, says Unicef report

      Palestinian children queue for food in Gaza
    • Thursday, 6 June, 2024
      The Big Read
      The unseen dangers of lead contamination in the UK

      As floods intensify, the threat of the toxic metal seeping into the food chain is as big a problem as sewage in rivers or air pollution

    • Wednesday, 5 June, 2024
      Medical science
      Scientists look to cancer drug to treat bowel disease

      ‘Gene desert’ research boosts knowledge of chronic disease mechanisms and promises to unlock novel therapies

      An illustration of Crohn’s disease
    • Wednesday, 5 June, 2024
      HTSI
      What The Laundress’s Gwen Whiting did next

      The cleaning guru is back with a new eco-range, The Fill

      Gwen Whiting, founder of The Fill, at home in Manhattan
    • Tuesday, 4 June, 2024
      Pharmaceuticals sector
      Panel advising US regulator rejects psychedelic MDMA as treatment for PTSD

      Non-binding vote on psychedelic drug will carry weight with FDA in blow to pharmaceutical developers

      Methylenedioxymethamphetamine (MDMA) commonly refered to as ecstasy
    Previous page You are on page 1 Next page

    Join us at an FT Live event

    Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

    FT Live
    Global Pharma and Biotech Summit
    Driving life sciences innovation in a disrupted world
    Tuesday, 5 NovemberIn-Person & Online Conference
    Explore all events

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

    Tools

    PortfolioFT AppFT Digital EditionFT EditAlerts HubBusiness School RankingsSubscription ManagerNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2024. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Israel-Hamas war
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
    • US
      • US Economy
      • Investing in America
      • US Companies
      • US Politics & Policy
      • US Presidential Election 2024
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
      • Artificial intelligence
      • Semiconductors
      • Cyber Security
      • Social Media
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Wealth Management
      • Moral Money
      • ETF Hub
      • Fund Management
      • Trading
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
    • Lex
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Europe's Start-Up Hubs
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      • Working It
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Alphaville
    • FT Edit
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Visual and data journalism
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT Feed
    • Portfolio
    • FT Digital Edition
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In